Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma

被引：0
|
作者：
Inga Peters
Natalia Dubrowinskaja
Michael Kogosov
Mahmoud Abbas
Jörg Hennenlotter
Christoph von Klot
Axel S Merseburger
Arnulf Stenzl
Ralph Scherer
Markus A Kuczyk
Jürgen Serth
机构：
[1] Hannover Medical School,Department of Urology and Urologic Oncology
[2] Hannover Medical School,Department of Pathology
[3] Eberhard Karls University of Tuebingen,Department of Urology
[4] Hannover Medical School,Department of Biometry
来源：
BMC Cancer | / 14卷
关键词：
Renal cell carcinoma; mRNA; Prognosis; DNA methylation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] GLUT1 Expression Is Related to Tumor Recurrence and Survival in Renal Cell Carcinoma Clear Cell Type
    Leite, Katia R. M.
    Carvalho, Paulo A.
    Pinheiro, Celine M.
    Reis, Sabrina T.
    Srougi, Miguel
    Nahas, William C.
    LABORATORY INVESTIGATION, 2017, 97 : 237A - 237A
  • [32] GLUT1 Expression Is Related to Tumor Recurrence and Survival in Renal Cell Carcinoma Clear Cell Type
    Leite, Katia R. M.
    Carvalho, Paulo A.
    Pinheiro, Celme M.
    Reis, Sabrina T.
    Srougi, Miguel
    Nahas, William C.
    MODERN PATHOLOGY, 2017, 30 : 237A - 237A
  • [33] ADVANCED PATHOLOGICAL STAGE ACCOUNTS FOR DECREASED RECURRENCE FREE SURVIVAL IN SMOKERS WITH RENAL CELL CARCINOMA
    Thong, Alan
    Ngo, Tin
    Leppert, John
    Jeon, Seung-Hyun
    Chung, Benjamin
    JOURNAL OF UROLOGY, 2013, 189 (04): : E530 - E530
  • [34] Decreased Expression of SATB2 Associates with Tumor Growth and Predicts Worse Outcome in Patients with Clear Cell Renal Cell Carcinoma
    Sliwinska-Jewsiewicka, Agnieszka
    Kowalczyk, Anna E.
    Krazinski, Bartlomiej E.
    Godlewski, Janusz
    Kwiatkowski, Przemyslaw
    Kiewisz, Jolanta
    Grzegrzolka, Jedrzej
    Dziegiel, Piotr
    Kmiec, Zbigniew
    ANTICANCER RESEARCH, 2018, 38 (02) : 839 - 846
  • [35] High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma
    Zhang, Haijian
    Liu, Yidong
    Xie, Huyang
    Liu, Weisi
    Fu, Qiang
    Yao, Dengfu
    Xu, Jiejie
    Gu, Jianxin
    ONCOTARGET, 2017, 8 (35) : 59777 - 59790
  • [36] Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma
    Mei, Jie
    Hu, Kehan
    Peng, Xiafeng
    Wang, Huiyu
    Liu, Chaoying
    MEDICINE, 2019, 98 (30)
  • [37] The Combination of Low Skeletal Muscle Mass and High Tumor Interleukin-6 Associates with Decreased Survival in Clear Cell Renal Cell Carcinoma
    Kays, Joshua K.
    Koniaris, Leonidas G.
    Cooper, Caleb A.
    Pili, Roberto
    Jiang, Guanglong
    Liu, Yunlong
    Zimmers, Teresa A.
    CANCERS, 2020, 12 (06) : 1 - 11
  • [38] PHD3 expression is a predictor of progression-free survival in clear cell renal cell carcinoma
    Tanaka, T.
    Kitamura, H.
    Torigoe, T.
    Hirohashi, Y.
    Masumori, N.
    Sato, N.
    Tsukamoto, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E199 - U615
  • [39] SELECT CONCURRENT CHROMOSOME 3P MUTATIONS PREDICT WORSE OVERALL AND RECURRENCE-FREE SURVIVAL IN CLEAR CELL RENAL CARCINOMA IN THE CANCER GENOME ATLAS
    Keith, Christopher
    Petros, John
    Rossi, Michael
    Arnold, Rebecca
    JOURNAL OF UROLOGY, 2016, 195 (04): : E918 - E918
  • [40] A methylomics-correlated nomogram predicts the recurrence free survival risk of kidney renal clear cell carcinoma
    Zhu, Xiuxian
    Ma, Xianxiong
    Wu, Chuanqing
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2021, 18 (06) : 8559 - 8576
12345